Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.21% | $22.46M | $547.45B | 87.20% | 81 Outperform | |
| Roche Holding AG | 1.21% | $12.25M | CHF285.32B | 42.71% | 73 Outperform | |
| Novartis | 1.21% | $12.25M | $304.38B | 52.88% | 80 Outperform | |
| Royal Bank Of Canada | 0.97% | $9.84M | $241.39B | 42.26% | 75 Outperform | |
| AstraZeneca | 0.93% | $9.45M | £229.75B | 29.12% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.70% | $7.15M | €261.02B | -28.22% | 78 Outperform | |
| Toyota Motor | 0.70% | $7.10M | ¥48.41T | 34.78% | 80 Outperform | |
| Rolls-Royce Holdings | 0.66% | $6.73M | £105.21B | 116.48% | 71 Outperform | |
| Unilever | 0.64% | $6.48M | $157.95B | 18.96% | 73 Outperform | |
| ― | 0.62% | $6.30M | ― | ― | ― |